Keyphrases
Placebo
100%
Overactive Bladder Symptom Score (OABSS)
100%
Relative Risk
60%
Quality of Life Improvement
40%
Weighted Mean Difference
40%
Cochrane
40%
Dry Mouth
40%
Tolterodine
40%
Randomized Trial
20%
Sensitivity Analysis
20%
Treatment Duration
20%
Meta-analysis
20%
Extracted Data
20%
Quality of Life Assessment
20%
Parallel Group Design
20%
Placebo Treatment
20%
Long-term Treatment
20%
Trial Quality
20%
Number of Trials
20%
Incontinence
20%
Urinary Incontinence
20%
Drug Choice
20%
Slow-release Formulations
20%
Bromide
20%
Sex Diagnosis
20%
Treatment Improvement
20%
Solifenacin
20%
Trospium Chloride
20%
Side Effects of Therapy
20%
Oxybutynin
20%
Darifenacin
20%
Propiverine
20%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Syndrome
100%
Cholinergic Receptor Blocking Agent
100%
Overactive Bladder
100%
Xerostomia
40%
Tolterodine
40%
Side Effect
20%
Prevalence
20%
Incontinence
20%
Carrageenan
20%
Solifenacin
20%
Trospium Chloride
20%
Urge Incontinence
20%
Darifenacin
20%
Propiverine
20%
Emepronium Bromide
20%
Oxybutynin
20%